LP237-F5
| Internal ID | dd2cde2b-f87d-4ac6-b092-67ceaabd2ae8 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-N-[1-[[(3S)-3-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-hydroxy-4-methylpentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]carbamoyl]hexan-3-yl]amino]-2-methyl-1-oxopropan-2-yl]-2-[[(2S)-5-amino-2-[[2-[[(2S)-3-(4-hydroxyphenyl)-2-[[(2S)-1-[2-methyl-2-(octanoylamino)propanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-2-methylpropanoyl]amino]-5-oxopentanoyl]amino]pentanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C65H108N14O16/c1-13-16-17-18-19-22-51(85)75-64(11,12)61(95)79-34-20-21-47(79)57(91)72-46(36-40-23-25-42(81)26-24-40)56(90)77-62(7,8)58(92)73-44(28-31-49(67)83)54(88)71-45(29-32-50(68)84)55(89)76-63(9,10)59(93)78-65(15-3,33-14-2)60(94)74-43(27-30-48(66)82)53(87)69-39(6)52(86)70-41(37-80)35-38(4)5/h23-26,38-39,41,43-47,80-81H,13-22,27-37H2,1-12H3,(H2,66,82)(H2,67,83)(H2,68,84)(H,69,87)(H,70,86)(H,71,88)(H,72,91)(H,73,92)(H,74,94)(H,75,85)(H,76,89)(H,77,90)(H,78,93)/t39-,41-,43-,44-,45-,46-,47-,65-/m0/s1 |
| InChI Key | XCWSPRIVWUZECV-SBBCGHSHSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C65H108N14O16 |
| Molecular Weight | 1341.60 g/mol |
| Exact Mass | 1340.80677341 g/mol |
| Topological Polar Surface Area (TPSA) | 481.00 Ų |
| XlogP | 1.30 |
| Atomic LogP (AlogP) | -0.20 |
| H-Bond Acceptor | 16 |
| H-Bond Donor | 15 |
| Rotatable Bonds | 43 |
| RefChem:154150 |
| CHEBI:224158 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9572 | 95.72% |
| Caco-2 | - | 0.8625 | 86.25% |
| Blood Brain Barrier | - | 0.7250 | 72.50% |
| Human oral bioavailability | - | 0.7857 | 78.57% |
| Subcellular localzation | Lysosomes | 0.5273 | 52.73% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8369 | 83.69% |
| OATP1B3 inhibitior | + | 0.9340 | 93.40% |
| MATE1 inhibitior | - | 0.9400 | 94.00% |
| OCT2 inhibitior | - | 0.7500 | 75.00% |
| BSEP inhibitior | + | 0.9726 | 97.26% |
| P-glycoprotein inhibitior | + | 0.7424 | 74.24% |
| P-glycoprotein substrate | + | 0.8903 | 89.03% |
| CYP3A4 substrate | + | 0.7386 | 73.86% |
| CYP2C9 substrate | - | 0.7904 | 79.04% |
| CYP2D6 substrate | - | 0.8206 | 82.06% |
| CYP3A4 inhibition | + | 0.5209 | 52.09% |
| CYP2C9 inhibition | - | 0.8620 | 86.20% |
| CYP2C19 inhibition | - | 0.7736 | 77.36% |
| CYP2D6 inhibition | - | 0.8035 | 80.35% |
| CYP1A2 inhibition | - | 0.9433 | 94.33% |
| CYP2C8 inhibition | + | 0.7361 | 73.61% |
| CYP inhibitory promiscuity | - | 0.9350 | 93.50% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8000 | 80.00% |
| Carcinogenicity (trinary) | Non-required | 0.6454 | 64.54% |
| Eye corrosion | - | 0.9896 | 98.96% |
| Eye irritation | - | 0.8959 | 89.59% |
| Skin irritation | - | 0.7812 | 78.12% |
| Skin corrosion | - | 0.8968 | 89.68% |
| Ames mutagenesis | - | 0.8100 | 81.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7081 | 70.81% |
| Micronuclear | + | 0.7200 | 72.00% |
| Hepatotoxicity | + | 0.5356 | 53.56% |
| skin sensitisation | - | 0.8812 | 88.12% |
| Respiratory toxicity | + | 0.7778 | 77.78% |
| Reproductive toxicity | + | 0.9000 | 90.00% |
| Mitochondrial toxicity | + | 0.8625 | 86.25% |
| Nephrotoxicity | - | 0.8217 | 82.17% |
| Acute Oral Toxicity (c) | III | 0.6620 | 66.20% |
| Estrogen receptor binding | + | 0.5385 | 53.85% |
| Androgen receptor binding | + | 0.7622 | 76.22% |
| Thyroid receptor binding | + | 0.7225 | 72.25% |
| Glucocorticoid receptor binding | + | 0.7951 | 79.51% |
| Aromatase binding | + | 0.7772 | 77.72% |
| PPAR gamma | + | 0.7742 | 77.42% |
| Honey bee toxicity | - | 0.7661 | 76.61% |
| Biodegradation | - | 0.9000 | 90.00% |
| Crustacea aquatic toxicity | + | 0.6689 | 66.89% |
| Fish aquatic toxicity | + | 0.8537 | 85.37% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.94% | 98.95% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.77% | 89.63% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.56% | 96.61% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 99.03% | 91.81% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 98.34% | 99.17% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.22% | 96.09% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 98.11% | 97.23% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.91% | 93.56% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 97.78% | 100.00% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 97.40% | 100.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 97.19% | 97.09% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 97.08% | 96.67% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 97.01% | 100.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.44% | 98.33% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 96.41% | 96.67% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 96.36% | 97.64% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 96.03% | 97.25% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 95.52% | 95.38% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 95.44% | 97.29% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 95.11% | 97.14% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 94.58% | 82.69% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 94.32% | 95.89% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 94.31% | 93.10% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.12% | 91.19% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.90% | 100.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 93.29% | 99.35% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 93.08% | 95.17% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.29% | 90.71% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 92.02% | 92.86% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 92.01% | 98.94% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 91.63% | 90.93% |
| CHEMBL242 | Q92731 | Estrogen receptor beta | 91.58% | 98.35% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 91.13% | 99.17% |
| CHEMBL3230 | O95977 | Sphingosine 1-phosphate receptor Edg-6 | 91.13% | 94.01% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 90.93% | 91.11% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 90.84% | 94.45% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 90.77% | 83.14% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 90.51% | 90.08% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 90.02% | 94.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 89.83% | 93.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 89.53% | 96.90% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 88.72% | 85.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 88.55% | 96.47% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 88.06% | 98.89% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 87.61% | 97.43% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 86.98% | 92.88% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 86.19% | 96.95% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 86.07% | 97.64% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 85.90% | 97.79% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.12% | 95.89% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 84.97% | 87.16% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 84.41% | 97.50% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 84.40% | 92.50% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 83.67% | 90.20% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 83.44% | 82.86% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 83.33% | 98.24% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 82.38% | 92.08% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 82.34% | 100.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 82.12% | 95.56% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 81.93% | 94.33% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 81.80% | 98.33% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 81.70% | 95.00% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 81.06% | 96.03% |
| CHEMBL2535 | P11166 | Glucose transporter | 80.16% | 98.75% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 80.09% | 96.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 10701649 |
| LOTUS | LTS0034314 |
| wikiData | Q77508576 |